Filing Details

Accession Number:
0000950172-24-000090
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-21 18:39:17
Reporting Period:
2024-03-19
Accepted Time:
2024-03-21 18:39:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1802450 Msp Recovery Inc. LIFW Services-Offices & Clinics Of Doctors Of Medicine (8011) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800682 Cano Health, Inc. 9725 Nw 117Th Avenue
Miami FL 33178
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2024-03-19 28,057 $0.77 2,280,303 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-03-20 46,246 $0.76 2,234,057 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-03-21 43,711 $0.75 2,190,346 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.76 to $0.795. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.775. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.771. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.